Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

Lung Cancer Prediction (LCP) review

#32 of 54 in Medical Imaging Analytics Software

A focused lung-screening workflow combining CT risk scoring with follow-up coordination.

5.7/10Editor score
Lung Cancer Prediction (LCP)5.7 Visit Optellum

Reviewed by iTechGuides Editors · Editorial team · Updated Nov 2026

Optellum Lung Cancer Prediction (LCP) is AI software within the Virtual Nodule Clinic platform for early lung cancer diagnosis. It is designed for mid-market and enterprise teams running lung cancer screening and pulmonary nodule follow-up programs. LCP analyzes CT images with deep learning and radiomics to produce a lung cancer prediction risk score, while supporting clinician decision-making rather than replacing it. The software is delivered through web and API access.

Its workflow coverage extends beyond image scoring. Natural-language processing of radiology reports helps discover patients with pulmonary nodules automatically, then the platform supports nodule triage, tracking and follow-up management. A centralized screening dashboard brings cases together, while automated follow-up alerts and letter generation help coordinate subsequent steps. EHR and PACS integration, along with Rapid Enterprise connectivity, position LCP for organizations that need screening analytics connected to existing clinical systems.

According to the published pricing model, purchasing requires contacting sales, and there is no free plan. The product carries FDA clearance and UKCA/CE marking, with GDPR and ISO27001 listed in its compliance profile. Email is the stated support channel. LCP is a focused choice for programs prioritizing pulmonary nodule risk assessment, prioritization and longitudinal follow-up. Teams seeking segmentation or quantification capabilities, broader organ coverage, or a self-service purchasing path should consider a different medical imaging analytics product. Its fit is strongest where EHR/PACS integration and centralized screening coordination matter as much as the CT risk score.

Lung Cancer Prediction (LCP) pros and cons

  • Where it wins
    • CT malignancy risk scoring combines deep learning and radiomics.
    • NLP discovers patients and supports nodule triage, tracking and follow-up.
    • EHR, PACS and Rapid Enterprise integrations connect screening workflows.
  • Where it doesn't
    • Pricing requires contacting sales, with no free plan.
    • No segmentation or quantification feature is provided.
    • Support is available through email only.

Lung Cancer Prediction (LCP) fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update